The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–229 of 229
Arora, S., Goyal, H., Aggarwal, P., & Kukar, A. (2012) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2011.12.033 · Cited by 41
Hoyer, F. F., Khoury, M., Slomka, H., Kebschull, M., Lerner, R., Lutz, B., Schött, H.-F., Lütjohann, D., Wojtalla, A., Becker, A., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.013 · Cited by 40
Zhang, Y., Sonnenberg, G. E., Baye, T. M., Littrell, J., Gunnell, J., DeLaForest, A., MacKinney, E. C., Hillard, C. J., Kissebah, A. H., Olivier, M., et al. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.122 · Cited by 38
The Hope and Fear of Rimonabant
Rumsfeld, J. S., & Nallamothu, B. K. (2008) · JAMA · doi:10.1001/jama.299.13.1601 · Cited by 38
Schaich, C. L., Shaltout, H. A., Brosnihan, K. B., Howlett, A. C., & Diz, D. I. (2014) · Physiological Reports · doi:10.14814/phy2.12108 · Cited by 38
Cardiovascular side effects related with use of “Bonzai”: Two case reports
Atik, S. U., Dedeoğlu, R., Varol, F., Çam, H., Eroğlu, A. G., & Saltık, L. (2015) · Türk Pediatri Arşivi · doi:10.5152/tpa.2015.2609 · Cited by 37
Cannabinoid receptor CB2 protects against balloon-induced neointima formation
Molica, F., Matter, C. M., Burger, F., Pelli, G., Lenglet, S., Zimmer, A., Pacher, P., & Steffens, S. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00444.2011 · Cited by 36
Self-citationCannabinoid CB 1 Receptor Antagonists for Atherosclerosis and Cardiometabolic Disorders
Pacher, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.178129 · Cited by 34
Self-citationCannabis Use and Outcomes in Patients With Aneurysmal Subarachnoid Hemorrhage
Behrouz, R., Birnbaum, L., Grandhi, R., Johnson, J. N., Misra, V., Palacio, S., Seifi, A., Topel, C. H., Garvin, R., & Caron, J.-L. R. (2016) · Stroke · doi:10.1161/strokeaha.116.013099 · Cited by 33
Paroxysmal atrial fibrillation after recreational marijuana smoking: another
Charbonney, E., Sztajzel, J. M., Poletti, P., & Rutschmann, O. (2005) · Swiss Medical Weekly · doi:10.4414/smw.2005.11014 · Cited by 31
Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis in Mice
Willecke, F., Zeschky, K., Rodríguez, A. O., Colberg, C., Auwärter, V., Kneisel, S., Hutter, M., Lozhkin, A. P., Hoppe, N., Wolf, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019405 · Cited by 29
Marijuana Smoking is Associated With Atrial Fibrillation
Korantzopoulos, P. G. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.001 · Cited by 29
Brancheau, D., Blanco, J. L. C., Gholkar, G., Patel, B. D., & Machado, C. (2015) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2015.10.003 · Cited by 28
Cappellano, G., Uberti, F., Caimmi, P. P., Pietronave, S., Mary, D., Dianzani, C., Micalizzi, E., Melensi, M., Boldorini, R. L., Nicosia, G., et al. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.003 · Cited by 28
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?
Steffens, S., & Pacher, P. (2015) · Current Drug Targets · doi:10.2174/1389450115666141202113225 · Cited by 28
Self-citationde Luis, D. A., Sagrado, M. G., Aller, R., Izaola, O., Conde, R., & Romero, E. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.12.019 · Cited by 25
Taquicardia ventricular por cannabis en trasplantado cardiaco
Sánchez-Lázaro, I. J., Bonet, L. A., Sancho-Tello, M. J., & Martínez‐Dolz, L. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70909-1 · Cited by 24
Overweight and Obesity as Determinants of Cardiovascular Risk: The Framingham Experience
Wilson, P. W. F., D'Agostino, R. B., Sullivan, L., Parise, H., & Kannel, W. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1867 · Cited by 22
Coronary thrombosis and marijuana smoking: a case report and narrative review of the literature
Marchetti, D., Spagnolo, A., Matteis, V. D., Filograna, L., & Giovanni, N. D. (2015) · Drug Testing and Analysis · doi:10.1002/dta.1898 · Cited by 22
The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity
Orsini, J., Blaak, C., Tam, E. L., Rajayer, S. R., Morante, J., Yeh, A., & Butala, A. (2015) · Case Reports in Critical Care · doi:10.1155/2015/542490 · Cited by 22
Marijuana use in acute coronary syndromes
Draz, E. I., Oreby, M. M., Elsheikh, E., Khedr, L. A., & Atlam, S. A. E.-M. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1240800 · Cited by 22
Hengstenberg, C. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000004 · Cited by 21
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage
Napoli, M. D., Zha, A. M., Godoy, D. A., Masotti, L., Schreuder, F. H. B. M., Popa‐Wagner, A., Behrouz, R., & from the MNEMONICH Registry (2016) · Cerebrovascular Diseases · doi:10.1159/000443532 · Cited by 21
Prolonged Atrial Fibrillation Precipitated by New-Onset Seizures and Marijuana Abuse
Singh, D., Huntwork, M. P., Shetty, V., Sequeira, G. M., & Akingbola, O. (2014) · PEDIATRICS · doi:10.1542/peds.2013-1831 · Cited by 20
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoE-Deficient Mice
Jehle, J., Hoyer, F. F., Schöne, B., Pfeifer, P., Schild, K., Jenniches, I., Bîndilă, L., Lutz, B., Lütjohann, D., Zimmer, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146267 · Cited by 20
Feng, Q., Jiang, L., Berg, R. L., Antonik, M., MacKinney, E. C., Gunnell, J., McCarty, C. A., & Wilke, R. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015779 · Cited by 17
A common functional promoter variant links CNR1 gene expression to HDL cholesterol level
Feng, Q., Vickers, K. C., Anderson, M. P., Levin, M. G., Chen, W., Harrison, D. G., & Wilke, R. A. (2013) · Nature Communications · doi:10.1038/ncomms2973 · Cited by 17
Shah, M. K., Garg, J., Patel, B. D., Guthier, J. L., & Freudenberger, R. S. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.055 · Cited by 17
CNR1 Genotype Influences HDL-Cholesterol Response to Change in Dietary Fat Intake
Silver, H. J., Niswender, K. D., Keil, C. D., Jiang, L., Feng, Q., Chiu, S., Krauss, R. M., & Wilke, R. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036166 · Cited by 8
Cited by
New approaches and challenges to targeting the endocannabinoid system
Di Marzo, V. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.115 · Cited by 480
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 358
New psychoactive substances: a review and updates
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967197 · Cited by 347
Page, R. L., Allen, L. A., Kloner, R. A., Carriker, C. R., Martel, C., Morris, A. A., Piano, M. R., Rana, J. S., Saucedo, J. F., & On behalf of the American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health; and Council on Quality of Care and Outcomes Research (2020) · Circulation · doi:10.1161/cir.0000000000000883 · Cited by 260
Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103381 · Cited by 236
Metadata
- Authors
- Pacher, P., Steffens, S., Haskó, G., Schindler, T. H., & Kunos, G.
- Venue
- Nature Reviews Cardiology
- Published
- 2017-09-14
- Volume
- 15
- Issue
- 3
- Pages
- 151-166
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W2754378617
- Cited by
- 439
- References
- 229
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.